Staff editor
Savita Bernal, Chief Business Officer at MaaT Pharma, discussed the Phase 3 trial (ARES) in patients with acute Graft-versus-Host-Disease with gastrointestinal involvement.
Christine Moissl-Eichinger (Medical University of Graz, Austria) explains the changes in the microbiome of astronauts.
The agreement will aid in the understanding of the microbiome in human disease.
The DGCCRF has announced that the use of the word “probiotic” can be allowed on the label of dietary supplements, as well as the health claim “contributes to the balance…
Fabio Grassi, Founder at MV BioTherapeutics SA, discussed how to understand the mechanisms of action for microbiome contributions to cancer therapeutic response in patients.
First patient to be administered Oncobax® AK, a live bacterial product based on a specific strain found in the gut microbiota, at Institut de Cancérologie Strasbourg Europe (ICANS) in Strasbourg,…
Felix Faupel, Chief Commercial Officer at Bacthera, discussed how the combination of the new Lonza Capsugel® Enprotect™ capsule and Bacthera services will accelerate time-to-human and time-to-market.
The OncobiotaLUNG assay is the first blood microbiome-driven liquid biopsy with proven effectiveness, including identifying cancer in its earliest stages
Gynecologist Franco Vicariotto and Virginia Franco, CEO and Co-Founder Yoni Solutions, discuss how personalized analysis and personalized therapy are within the reach of today's woman.
Funding round led by Shanghai Healthcare Capital. The financing round will enable Biomica to forge ahead, developing its pipeline of microbiome-based therapeutics.
